IL1B and myocardial infarction: Treatment with MCB-613 was shown to greatly reduce fibrotic tissue in murine hearts following myocardial infarction, illustrating the overall effect of IL-1β inhibition and the reduction of inflammation in the microenvironment (Mullany et al., 2020).